Genre: Technical Report / Copyright: Public domain - Digital Collections - National Library of Medicine Search Results

Start Over Genre Technical Report ✖ Copyright Public domain ✖

451. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, October 2017
Subject(s):: Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
Fraud -- prevention & control
Opioid-Related Disorders
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

452. Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, October 2017
Subject(s):: Federal Government
Health Benefit Plans, Employee -- statistics & numerical data
Insurance Carriers
Forecasting
Government Employees
Health Benefit Plans, Employee -- trends
Medicare
Humans
United States

453. Counternarcotics: overview of U.S. efforts in the Western Hemisphere : report to the ranking member, Committee on Foreign Affairs, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, October 2017
Subject(s):: Drug and Narcotic Control -- organization & administration
Drug Trafficking -- prevention & control
Government Agencies
Street Drugs
Drug and Narcotic Control -- economics
Drug and Narcotic Control -- trends
Forecasting
Information Dissemination
Interinstitutional Relations
Humans
North America
South America
United States

454. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, October 2017
Subject(s):: Drug and Narcotic Control
Prescription Drug Diversion -- prevention & control
Prescription Drug Misuse -- prevention & control
Voluntary Programs
Government Programs
Pharmacies
Prescription Drugs
State Government
Humans
United States
United States. Drug Enforcement Administration.

455. Low-dose radiation: interagency collaboration on planning research could improve information on health effects : testimony before the Subcommittee on Energy, Committee on Science, Space, and Technology, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, November 1, 2017
Subject(s):: Government Agencies
Interinstitutional Relations
Radiation Effects
Radiation, Ionizing
Research
Radiation Dosage
Humans
United States
United States. Department of Energy.
United States. Environmental Protection Agency.
United States. Food and Drug Administration.
U.S. Nuclear Regulatory Commission.

456. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, November 2, 2017
Subject(s):: Biological Warfare Agents
Chemical Warfare Agents
Government Regulation
Laboratories
Bacterial Toxins
Interinstitutional Relations
Humans
Canada
United Kingdom
United States
Centers for Disease Control and Prevention (U.S.)
United States. Animal and Plant Health Inspection Service.

457. Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress

458. Sunscreen: FDA reviewed applications for additional active ingredients and determined more data needed : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, November 2017
Subject(s):: Drug Approval
Nonprescription Drugs
Sunscreening Agents
Consumer Product Safety
Humans
United States
United States. Food and Drug Administration.

459. Food safety: FDA continues to evaluate and respond to business concerns about the produce rule : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, November 2017
Subject(s):: Commerce
Food Contamination
Food Safety
Fruit
Vegetables
Water Pollution
Water Supply
Humans
United States
United States. Food and Drug Administration.

460. VA health care: improved policies and oversight needed for reviewing and reporting providers for quality and safety concerns : report to the chairman, Committee on Veterans' Affairs, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, November 2017
Subject(s):: Clinical Competence
Government Regulation
Hospitals, Veterans
Patient Safety
Quality of Health Care
Documentation
Health Policy
Veterans Health
Humans
United States
United States. Veterans Health Administration.

« Previous
Next »
1
2
…
42
43
44
45
46
47
48
49
50
…
179
180